calibration plot (STATA Corporation)
STATA Corporation is a verified supplier 
90
Structured Review
STATA Corporation
calibration plot
Calibration Plot, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calibration+plot/calibration+plots/pmc12190336-114-1-19
Average 90 stars, based on 1 article reviews
Calibration Plot, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calibration+plot/calibration+plots/pmc12190336-114-1-19
Average 90 stars, based on 1 article reviews
calibration plot - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients"
Article Title: Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients
Journal: Cancers
doi: 10.3390/cancers17121932
Figure Legend Snippet: ( A ) Cubic 4-knot spline and ( B ) calibration plot of the model.
Techniques Used:
Related Articles
Comparison:Article Title: N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas Article Snippet: The calibration was estimated using the Hosmer and Lemeshow goodness of fit statistics, while the calibration plot was developed using the Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Software:Article Title: N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas Article Snippet: The calibration was estimated using the Hosmer and Lemeshow goodness of fit statistics, while the calibration plot was developed using the Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Infection:Article Title: N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas Article Snippet: The calibration was estimated using the Hosmer and Lemeshow goodness of fit statistics, while the calibration plot was developed using the Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Biomarker Discovery:Article Title: N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas Article Snippet: The calibration was estimated using the Hosmer and Lemeshow goodness of fit statistics, while the calibration plot was developed using the Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a Article Title: Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 Article Snippet: Where helpful, we also used a |